Screening of Natural Antidiabetic Agents
Diabetes mellitus (DM) is a metabolic disease characterized by a relative or absolute lack of insulin that leads to hyperglycaemia. Approximately two to five million cases of deaths result from diabetes each year. As of 2017, there are over 425 million sufferers of DM worldwide (representing over 8.3% of the adult population) and a projected increase to 629 million by the year 2045. Every year, millions of dollars are committed in the global health care and in research and development of effective antidiabetic medications. So far, tremendous progress has been made in the search for safer natural antidiabetic agents but more needs to be done because of the multifactorial nature of diabetes and its comorbidities. This chapter details the various methods involved in the screening of natural antidiabetic agents. It takes into account the various in silico tools, in vitro and animal models. The methods are presented in a clear and concise manner to aid easy adoption and replications.
KeywordsDiabetes mellitus Screening of antidiabetic agents α-glucosidase inhibitors Insulin Hyperglycaemia Drug discovery
- Allen RE, Hughes TD, Ng JL, Ortiz RD, Ghantous MA, Bouhali O, Frogue P, Arredouani A. Mechanisms behind the immediate effects of Roux-en-Y gastric bypass surgery on type 2 diabetes. Theor Biol Med Model. 2013;10(45):1–19.Google Scholar
- American Diabetes Association. Diabetes Care. 2015; 38(Supplement 1): S8-S16. https://doi.org/10.2337/dc15-S005. Available: http://care.diabetesjournals.org/content/38/Supplement_1/S8 Retrieved: 9th August, 2018.
- Ansarullah BB, Dwivedi M, Laddha NC, Begum R, Hardikar AA, Ramachandran A. Antioxidant rich flavonoids from Oreocnide integrifolia enhance glucose uptake and insulin secretion and protects pancreatic β-cells from streptozotocin insult. BMC Complement Altern Med. 2011;11:126. https://doi.org/10.1186/1472-6882-11-126.CrossRefPubMedPubMedCentralGoogle Scholar
- Dsouza D, Lakshmidev N. Models to study in vitro antidiabetic activity of plants: a review. Int J Pharm Bio Sci. 2015;6(3):732–41.Google Scholar
- Epand RM, Stafford AR, Tyers M, Nieboer E. Mechanism of action of diabetogenic zinc chelating agents. Model Syst Stud Mol Pharmacol. 1985;27(3):366–74.Google Scholar
- Etuk EU. Animals models for studying diabetes mellitus. Agric Biol J N Am. 2010;1:130–4.Google Scholar
- Hussain F, Arif M, Sheikh MA. Prevalence of diabetic retinopathy in Faisalabad, Pakistan: a population based study. Turk J Med Sci. 2011;41(4):735–42.Google Scholar
- International Diabetes Federation. IDF diabetes atlas – 8th edition. Powerpoint presentation slide 3–4. 2017. Available: http://diabetesatlas.org/component/attachments/?task=download&id=271. Retrieved: 9th Aug 2018.
- Manikandan R, Anand AV, Kumar S, Pushpa. Phytochemical and in vitro antidiabetic activity of Psidium Guajava leaves. Pharm J. 2016;8(4):392–4.Google Scholar
- McIntosh CHS, Pederson RA. Non-insulin dependent animal models of diabetes mellitus. In: McNeil JH, editor. Experimental models of diabetes. Boca Raton: CRC Press LLC; 1999. p. 337–98.Google Scholar
- McNeil JH. Experimental models of diabetes. Boca Raton: CRC Press LLC; 1999.Google Scholar
- Nuss JM, Wagman AS. Recent advances in therapeutic approaches to type2 diabetes. Annu Rep Med Chem. 2000;35:211–20.Google Scholar
- Ozturk Y, Altan VM, Yildizoğlu-Ari N. Effects of experimental diabetes and insulin on smooth muscle functions. Pharmacol Rev. 1999;48:69–112.Google Scholar
- Rodrigues R. A comprehensive review: the use of animal models in diabetes research. J Anal Pharm Res. 2016;3(5):1–5.Google Scholar
- Saidu Y, Muhammad SA, Abbas AY, Onu A, Tsado IM, Muhammad L. In vitro screening for protein tyrosine phosphatase 1B and dipeptidyl peptidase IV inhibitors from selected Nigerian medicinal plants. J Intercult Ethnopharmacol. 2017;6(2):154–7. https://doi.org/10.5455/jice.20161219011346.CrossRefPubMedGoogle Scholar
- Scheen AJ, De Hert M. Risque de diabète sucré sous antipsychotiques atypiques. Med Hyg (Geneve). 2004;62:1591–6.Google Scholar
- Shafrir E. Diabetes in animals: contribution to the understanding of diabetes by study of its etiopathology in animal models. In: Porte D, Sherwin RS, Baron A, editors. Diabetes mellitus. New York: McGraw-Hill; 2003. p. 231–55.Google Scholar
- Tripathi V, Verma J. Different models used to induce diabetes a comprehensive review. Int J Pharm Pharm Sci. 2014;6:29–32.Google Scholar
- Varmaan V, Rani Y, Avupati V. In silico based virtual screening for bioactive PPAR-y agonists. Indo Am J Pharm Sci. 2016;3(10):1237–75.Google Scholar
- WHO. Global Health Estimates (GHE), 2000–2015 estimates. Geneva: World Health Organization; 2017. Available: http://www.who.int/mediacentre/factsheets/fs312/en/. Accessed on 26 July 2018.Google Scholar
- Wu J, Yan L. Streptozotocin-induced type 1 diabetes in rodents as a model for studying.pdf>. Diabetes, Metab Syndr Obes Targets Ther Diabetes, Metab Syndr Obes: Targets Ther. 2015;8:181–8.Google Scholar